Alternaria is associated with asthma symptoms and exhaled NO among NYC children

Effect of inhaled corticosteroids on microbiome and microbial correlations in asthma over a nine-month period

The effect of inhaled corticosteroids (ICS) on airway microbiome requires longitudinal research to be corroborated. Asthma patients, not undergoing ICS treatment (baseline), were enrolled and prescribed with ICS; all of these patients were followed up with regular visits at 3 months (visit 1) and 9 months (visit 2). Induced sputum was collected, fungal microbiota (mycobiome) and bacterial microbiota (bacteriome) were estimated using 16S rRNA and Internal Transcribed Spacer (ITS) sequencing. Bacterial α diversity indices were not significantly different among the baseline, visit 1 and visit 2. Visit 1 showed lower fungal evenness than the baseline, visit 2 showed lower fungal diversity and evenness than the baseline. Fungal, but not bacterial, community compositions differed significantly among the baseline, visit 1 and visit 2. The most abundant bacterial phyla and genera did not differ significantly among the baseline, visit 1 and visit 2. Compared with the baseline, visit 1 showed significantly increased frequency of fungal phylum Ascomycota and lower frequency of Basidiomycota. We found sharply decreased fungal genera Wallemia, Cladosporium, Penicillium, and Alternaria in visit 1 and visit 2 compared with the baseline, although the differences were not statistically significant. We also found the proportion of Basidiomycota was positively correlated with percentages of sputum eosinophils and neutrophils. The proportions of Saccharomyces, Wallemia, and Aplosporella were positively correlated with percentage of sputum eosinophils. Moreover, we identified distinct inter- and intra-kingdom interactions in baseline, visit 1 and visit 2. Therefore, ICS use altered the airway microbial diversity, evenness, community composition and microbial connections.

Alternaria as an Inducer of Allergic Sensitization

Alternaria alternata is a saprophytic mold whose spores are disseminated in warm dry air, the typical weather of the Mediterranean climate region (from 30° to 45°), with a peak during the late summer and early autumn. Alternaria spores are known to be biological contaminants and a potent source of aeroallergens. One consequence of human exposure to Alternaria is an increased risk of developing asthma, with Alt a 1 as its main elicitor and a marker of primary sensitization. Although the action mechanism needs further investigation, a key role of the epithelium in cytokine production, TLR-activated alveolar macrophages and innate lymphoid cells in the adaptive response was demonstrated. Furthermore, sensitization to A. alternata seems to be a trigger for the development of co-sensitization to other allergen sources and may act as an exacerbator of symptoms and an elicitor of food allergies. The prevalence of A. alternata allergy is increasing and has led to expanding research on the role of this fungal species in the induction of IgE-mediated respiratory diseases. Indeed, recent research has allowed new perspectives to be considered in the assessment of exposure and diagnosis of fungi-induced allergies, although more studies are needed for the standardization of immunotherapy formulations.

Indoor Microbial Exposures and Chronic Lung Disease: From Microbial Toxins to the Microbiome

Effects of environmental microbial exposures on human health have long been of interest. Microbes were historically assumed to be harmful, but data have suggested that microbial exposures can modulate the immune system. We focus on the effects of indoor environmental microbial exposure on chronic lung diseases. We found contradictory data in bacterial studies using endotoxin as a surrogate for bacterial exposure. Contradictory data also exist in studies of fungal exposure. Many factors may modulate the effect of environmental microbial exposures on lung health, including coexposures. Future studies need to clarify which method of assessing environmental microbial exposures is most relevant.

The composition of microbial aerosols, PM2.5, and PM10 in a duck house in Shandong province, China

Poultry-emitted air pollutants, including microbial aerosols and particulate matter, have raised concerns due to their potential negative effects on human health and the environment. High concentrations of microbial aerosols can also significantly affect duck production performance, leading to immunosuppression and increased disease susceptibility. We determined the concentrations, distributions, and biological components of the microbial aerosols and particulate matter in a duck house environment. The concentration ranges of the bacteria, fungi, Gram-negative bacteria, Escherichia coli, and endotoxin in the duck houses were 3.3 to 5.2 × 104 CFU/m3, 3.8 to 11.9 × 103 CFU/m3, 2.1 to 3.6 × 103 CFU/m3, 1.3 to 2.7 × 102 CFU/m3, and 0.65 to 2.2 × 103 EU/m3, respectively. We also found the endotoxin levels were higher than the standard that can cause pneumonia (2,000 EU/m3). The concentration ranges of the PM2.5 and PM10 samples were 1.1 to 1.6 × 102 μg/m3 and 1.2 to 1.9 × 102 μg/m3, respectively. At the phylum level, the top 5 bacteria identified in the PM2.5 fraction were Actinobacteria, Firmicutes, Proteobacteria, Bacteroidetes, and Fusobacteria, with Actinobacteria (50.55%) as the most abundant. At the genus level, 293 bacterial groups were identified. Actinobacteria (39.01%) was the most abundant phylum, followed by Firmicutes (5.44%) and Proteobacteria (4.56%). The bacterial distributions that differed between the PM2.5 and PM10 samples were Lactobacillales, Bacilli, Firmicutes, and Bacteroidetes; the fungi that differed were Microbotryomycetes, Sporidiobolales, Agaricomycetes, and Polyporates. Microbial allergens and pathogens were also identified. Corynebacterium had a relative abundance of more than 30% in the PM2.5 and PM10 distributions. Aspergillus was the main fungal allergen and opportunistic pathogen, with a relative abundance of 10%. In conclusion, our research supports that the microbial composition in the duck house environment poses a potential threat to the health of both the ducks and the duck house workers.

Interaction of Alt a 1 with SLC22A17 in the airway mucosa

BACKGROUND

Despite all the efforts made up to now, the reasons that facilitate a protein becoming an allergen have not been elucidated yet. Alt a 1 protein is the major fungal allergen responsible for chronic asthma, but little is known about its immunological activity. Our main purpose was to investigate the ligand-dependent interactions of Alt a 1 in the human airway epithelium.

METHODS

Alt a 1 with and without its ligand (holo- and apo- forms) was incubated with the pulmonary epithelial monolayer model, Calu-3 cells. Allergen transport and cytokine production were measured. Pull-down and immunofluorescence assays were employed to identify the receptor of Alt a 1 using the epithelial cell model and mouse tissues. Receptor-allergen-ligand interactions were analyzed by computational modeling.

RESULTS

The holo-form could activate human monocytes, PBMCs, and polarized airway epithelial (Calu-3) cell lines. The allergen was also transported through the monolayer, without any alteration of the epithelial integrity (TEER). Alt a 1 also induced the production of proinflammatory IL8 and specific epithelial cytokines (IL33 and IL25) by Calu-3 cells. The interaction between epithelial cells and holo-Alt a 1 was found to be mediated by the SLC22A17 receptor, and its recognition of Alt a 1 was explained in structural terms.

CONCLUSIONS

Our findings identified the Alt a 1 ligand as a central player in the interaction of the allergen with airway mucosa, shedding light into its potential role in the immunological response, while unveiling its potential as a new target for therapy intervention.

Advances in asthma, asthma-COPD overlap, and related biologics in 2018

Over the past year, numerous important advances in our understanding of multiple aspects of asthma, ranging from disease pathogenesis to epidemiology to therapeutics, have been reported. This review is a compilation of highlights from articles published largely in the Journal of Allergy and Clinical Immunology and supplemented by articles published elsewhere that have substantially advanced the fields of asthma, chronic obstructive pulmonary disease (COPD), and asthma-COPD overlap and biologic therapies for these disorders. The intention of this article is not to provide a comprehensive review but rather to focus on several areas that have developed quickly and/or received extensive attention from our readers.